The current study aimed to test the hypothesis of whether expressions of adropin and afamin change between patients in various stages of CKD with change in the renal parameters and CKD-MBD parameters to assess the renal function and cardiovascular health. Here, AFM is linked to Marchiafava-Bignami disease.